UBS Group
WST icon

UBS Group’s West Pharmaceutical WST Stock Holding History

UBS Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.64M Buy
18,500
+4,500
+32% +$1.38M ﹤0.01% 3877
2026
Q1 		$3.51M Hold
14,000
– – ﹤0.01% 4435
2025
Q4 		$3.85M Hold
14,000
– – ﹤0.01% 4298
2025
Q3 		$3.67M Buy
+14,000
New +$3.4M ﹤0.01% 4353
2015
Q1 		– Sell
-500
Closed -$27K – 9452
2014
Q4 		$27K Buy
+500
New +$25K ﹤0.01% 7234

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

UBS Group's WST Position: Q2 2026 in Review

UBS Group increased its West Pharmaceutical (WST) stake by 36% in Q2 2026, buying an estimated $30.2M and bringing the position to 374,361 shares worth $134M. The position accounts for 0.02% of the portfolio, ranked #920.

UBS Group first reported a position in WST in Q4 2014 and has held it in 47 quarters since. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • UBS Group held 374,361 shares of West Pharmaceutical worth $134M as of Q2 2026.
  • UBS Group bought 98,853 West Pharmaceutical shares in Q2 2026, an estimated $30.2M.
  • West Pharmaceutical made up 0.02% of UBS Group's portfolio in Q2 2026, its #920 holding.
  • UBS Group first reported a position in West Pharmaceutical in Q4 2014 and has held it in 47 quarters since.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.